{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:01:09Z","timestamp":1784203269369,"version":"3.55.0"},"reference-count":38,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Although myasthenia gravis (MG) primarily manifests as weakness of oculo-bulbar, axial and appendicular muscles, the disease and its treatments are associated with many comorbid conditions that impact patients\u2019 quality of life. Patients frequently experience secondary autoimmunity, cardiovascular and endocrine dysfunction, fatigue, sleep and mental health disorders. MG and its treatments can also be an important source of social and economic burden on patients. This review aims to elaborate on the multi-morbid nature of MG and to provide an approach for recognising and managing relevant comorbidities with an emphasis on preventative health.<\/jats:p>","DOI":"10.1136\/pn-2025-004656","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T18:25:30Z","timestamp":1764008730000},"page":"216-223","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Optimising well-being in myasthenia gravis: a multidisciplinary approach"],"prefix":"10.1136","volume":"26","author":[{"given":"Benjamin","family":"Beland","sequence":"first","affiliation":[{"name":"Department of Neurology, University of California San Francisco, San Francisco, California, USA"},{"name":"Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Dhawan","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-8803","authenticated-orcid":false,"given":"Pritikanta","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2026051402150810000_26.3.216.1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-57825-1","article-title":"Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations","volume":"14","author":"Anderson","year":"2024","journal-title":"Sci Rep"},{"key":"2026051402150810000_26.3.216.2","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2025-004655"},{"key":"2026051402150810000_26.3.216.3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: a Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"J Intern Med"},{"key":"2026051402150810000_26.3.216.4","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.537","article-title":"Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course","volume":"6","author":"Kubiszewska","year":"2016","journal-title":"Brain Behav"},{"key":"2026051402150810000_26.3.216.5","doi-asserted-by":"crossref","first-page":"1223322","DOI":"10.3389\/fimmu.2023.1223322","article-title":"Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"2026051402150810000_26.3.216.6","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.12998\/wjcc.v12.i26.5863","article-title":"Cardiac implications in myasthenia gravis","volume":"12","author":"Elmati","year":"2024","journal-title":"World J Clin Cases"},{"key":"2026051402150810000_26.3.216.7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jns.2011.05.028","article-title":"Cardiac autonomic control in patients with myasthenia gravis and thymoma","volume":"307","author":"Peric","year":"2011","journal-title":"J Neurol Sci"},{"key":"2026051402150810000_26.3.216.8","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1007\/s10072-023-06750-8","article-title":"Effects of comorbid diseases on clinical outcomes in patients with myasthenia gravis","volume":"44","author":"Ozdemir","year":"2023","journal-title":"Neurol Sci"},{"key":"2026051402150810000_26.3.216.9","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8058946","article-title":"Electrocardiography as the First Step for the Further Examination of Cardiac Involvement in Myasthenia Gravis","volume":"2016","author":"Kato","year":"2016","journal-title":"Biomed Res Int"},{"key":"2026051402150810000_26.3.216.10","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/ene.14996","article-title":"The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequency","volume":"28","author":"Trillenberg","year":"2021","journal-title":"Eur J Neurol"},{"key":"2026051402150810000_26.3.216.11","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2024-004257"},{"key":"2026051402150810000_26.3.216.12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/jbmr\/zjae043","article-title":"Risk of fracture in patients with myasthenia gravis: a nationwide cohort study in Korea","volume":"39","author":"Park","year":"2024","journal-title":"J Bone Miner Res"},{"key":"2026051402150810000_26.3.216.13","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/art.42646","article-title":"2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis","volume":"75","author":"Humphrey","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026051402150810000_26.3.216.14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s13300-023-01393-6","article-title":"Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes","volume":"14","author":"Barker","year":"2023","journal-title":"Diabetes Ther"},{"key":"2026051402150810000_26.3.216.15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/ene.14153","article-title":"Serious infections in patients with myasthenia gravis: population-based cohort study","volume":"27","author":"Kassardjian","year":"2020","journal-title":"Eur J Neurol"},{"key":"2026051402150810000_26.3.216.16","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26689"},{"key":"2026051402150810000_26.3.216.17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9834","article-title":"Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia Gravis","volume":"6","author":"Alcantara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026051402150810000_26.3.216.18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/mus.28328","article-title":"International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Disease","volume":"71","author":"Bacher","year":"2025","journal-title":"Muscle Nerve"},{"key":"2026051402150810000_26.3.216.19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-210722","article-title":"Physical Activity and Sedentary Behaviour in People with Myasthenia Gravis: A Cross-Sectional Study","volume":"9","author":"Alsop","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"2026051402150810000_26.3.216.20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/PHM.0000000000000538","article-title":"Benefits of Comprehensive Rehabilitation Therapy in Thymectomy for Myasthenia Gravis: A Propensity Score Matching Analysis","volume":"96","author":"Ambrogi","year":"2017","journal-title":"Am J Phys Med Rehabil"},{"key":"2026051402150810000_26.3.216.21","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2923907","article-title":"Respiratory Muscle Training Improves Functional Outcomes and Reduces Fatigue in Patients with Myasthenia Gravis: A Single-Center Hospital-Based Prospective Study","volume":"2020","author":"Hsu","year":"2020","journal-title":"Biomed Res Int"},{"key":"2026051402150810000_26.3.216.22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.nmd.2020.06.010","article-title":"Fatigue in patients with myasthenia gravis. A systematic review of the literature","volume":"30","author":"Ruiter","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"2026051402150810000_26.3.216.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-0184-2"},{"key":"2026051402150810000_26.3.216.24","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26069"},{"key":"2026051402150810000_26.3.216.25","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1080\/09638288.2021.2022221","article-title":"The effects of spinal stabilization exercises in patients with myasthenia gravis: a randomized crossover study","volume":"44","author":"Ceren","year":"2022","journal-title":"Disabil Rehabil"},{"key":"2026051402150810000_26.3.216.26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JND-170299","article-title":"A Physical and Psychological Approach to Managing Fatigue in Myasthenia Gravis: A Pilot Study","volume":"5","author":"Farrugia","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"2026051402150810000_26.3.216.27","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00481","article-title":"Risk of Depressive Disorders Following Myasthenia Gravis: A Nationwide Population-Based Retrospective Cohort Study","volume":"10","author":"Chu","year":"2019","journal-title":"Front Psychiatry"},{"key":"2026051402150810000_26.3.216.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22078-3","article-title":"Mental health in myasthenia gravis patients and its impact on caregiver burden","volume":"12","author":"Marbin","year":"2022","journal-title":"Sci Rep"},{"key":"2026051402150810000_26.3.216.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-020-01802-4","article-title":"Prospective study of stress, depression and personality in myasthenia gravis relapses","volume":"20","author":"Bogdan","year":"2020","journal-title":"BMC Neurol"},{"key":"2026051402150810000_26.3.216.30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13548506.2020.1807577","article-title":"Post-traumatic stress disorder symptoms after respiratory insufficiency in patients with myasthenia gravis","volume":"26","author":"Liu","year":"2021","journal-title":"Psychol Health Med"},{"key":"2026051402150810000_26.3.216.31","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1589\/jpts.27.2013","article-title":"Sleep disorders in patients with myasthenia gravis: a systematic review","volume":"27","author":"Fernandes Oliveira","year":"2015","journal-title":"J Phys Ther Sci"},{"key":"2026051402150810000_26.3.216.32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4103\/neuroindia.NI_804_16","article-title":"Analysis of mortality and related factors in 2195 adult myasthenia gravis patients in a 10-year follow-up study","volume":"65","author":"Liu","year":"2017","journal-title":"Neurol India"},{"key":"2026051402150810000_26.3.216.33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5664\/jcsm.3626","article-title":"CPAP therapy reverses weakness of myasthenia gravis: role of obstructive sleep apnea in paradoxical weakness of myasthenia gravis","volume":"10","author":"Ji","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"2026051402150810000_26.3.216.34","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1266862","article-title":"Treatment of insomnia in myasthenia gravis-A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia","volume":"14","author":"Yan","year":"2023","journal-title":"Front Neurol"},{"key":"2026051402150810000_26.3.216.35","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1147489","article-title":"Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs","volume":"11","author":"Hughes","year":"2023","journal-title":"Front Public Health"},{"key":"2026051402150810000_26.3.216.36","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s12325-023-02604-z","article-title":"People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies","volume":"40","author":"Dewilde","year":"2023","journal-title":"Adv Ther"},{"key":"2026051402150810000_26.3.216.37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40273-020-00912-8","article-title":"Economic Costs of Myasthenia Gravis: A Systematic Review","volume":"38","author":"Landfeldt","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"2026051402150810000_26.3.216.38","first-page":"517","article-title":"Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis","volume":"30","author":"Lien","year":"2024","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2025-004656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:15:53Z","timestamp":1778750153000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2025-004656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5,14]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/pn-2025-004656"],"URL":"https:\/\/doi.org\/10.1136\/pn-2025-004656","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}